1494 related articles for article (PubMed ID: 3701387)
1. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast.
Chevinsky AH; Ferrara J; James AG; Minton JP; Young D; Farrar WB
Surgery; 1990 Oct; 108(4):612-7; discussion 617-8. PubMed ID: 2218870
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
5. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
Kuru B; Bozgul M
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
[TBL] [Abstract][Full Text] [Related]
6. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?
Chua B; Ung O; Taylor R; Boyages J
ANZ J Surg; 2002 Nov; 72(11):786-92. PubMed ID: 12437688
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review.
Lee MC; Plews R; Rawal B; Kiluk JV; Loftus L; Laronga C
Ann Surg Oncol; 2012 Jun; 19(6):1818-24. PubMed ID: 22203185
[TBL] [Abstract][Full Text] [Related]
9. Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections.
Rosen PP; Lesser ML; Kinne DW; Beattie EJ
Ann Surg; 1983 Mar; 197(3):276-83. PubMed ID: 6830335
[TBL] [Abstract][Full Text] [Related]
10. [Axillary skip metastases in breast cancer].
Sun JY; Ning LS
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):352-5. PubMed ID: 18953834
[TBL] [Abstract][Full Text] [Related]
11. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
12. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
13. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.
Kuerer HM; Newman LA; Fornage BD; Dhingra K; Hunt KK; Buzdar AU; Ames FC; Ross MI; Feig BW; Hortobagyi GN; Singletary SE
Ann Surg Oncol; 1998 Dec; 5(8):673-80. PubMed ID: 9869512
[TBL] [Abstract][Full Text] [Related]
14. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial.
Christensen SB; Jansson C
Eur J Surg; 1993 Mar; 159(3):159-62. PubMed ID: 8102890
[TBL] [Abstract][Full Text] [Related]
15. The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis.
Gaglia P; Bussone R; Caldarola B; Lai M; Jayme A; Caldarola L
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):849-54. PubMed ID: 3653201
[TBL] [Abstract][Full Text] [Related]
16. Level III axillary lymph nodes involvement in node positive breast cancer received neoadjuvant chemotherapy.
Fan Z; Li J; Wang T; Xie Y; Fan T; Lin B; Ouyang T
Breast; 2013 Dec; 22(6):1161-5. PubMed ID: 24080493
[TBL] [Abstract][Full Text] [Related]
17. [Axillary lymph node dissection in clinically node-positive breast cancer].
Iwata H; Miura S
Nihon Geka Gakkai Zasshi; 2002 Nov; 103(11):831-4. PubMed ID: 12478861
[TBL] [Abstract][Full Text] [Related]
18. [Exploration of the extent of axillary dissection for patients with node positive primary breast cancer].
Ouyang T; Li JF; Wang TF; Lin BY
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):298-300. PubMed ID: 15842936
[TBL] [Abstract][Full Text] [Related]
19. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.
Yu J; Li G; Li J; Wang Y
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):874-8. PubMed ID: 15708269
[TBL] [Abstract][Full Text] [Related]
20. [Axillary lymph node metastases in breast cancer. Anatomo-clinical correlation and surgical approach].
Coroş MF; Stolnicu S; Georgescu R; Roşca A; Sorlea S; Dobre A; Podeanu D; Pălăsan A; Man C; Turcan C
Chirurgia (Bucur); 2009; 104(5):557-64. PubMed ID: 19943554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
